Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate immune pattern recognition receptors (PRRs) and adaptive immune receptors represent the two primary sensing systems of the vertebrate immune system. PRRs, including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), are germline-encoded proteins that detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Source: StatPearls, Innate Immunity). In contrast, adaptive immune receptors, specifically T-cell receptors (TCRs) and B-cell receptors (BCRs), are generated through somatic recombination, allowing for the recognition of a vast array of specific antigens (Source: Janeway's Immunobiology). These receptor systems are critical for host defense; however, their overactivation or failure to distinguish self from non-self leads to conditions such as sepsis, rheumatoid arthritis, and systemic lupus erythematosus (Source: Nature Reviews Immunology). Pharmacological intervention targeting these receptors includes the use of TLR agonists like Imiquimod for viral infections and skin cancers, as well as monoclonal antibodies that modulate adaptive signaling, such as Pembrolizumab for oncology (Source: FDA, PubMed). The complexity of these systems presents challenges in drug development, particularly regarding the risk of systemic inflammatory responses or profound immunosuppression.
Agonism or antagonism of specific innate or adaptive receptors to modulate immune signaling pathways.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate immune pattern recognition receptors and adaptive immune receptors (PRRs and AIRs).